Neuroendocrine Probes as Biological Markers of Affective Disorders: New Directions*
Author:
- 1 November 1989
- journal article
- other
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 34 (8) , 819-823
Abstract
Numerous endocrine abnormalities are found in depressive illness and, among these, several have been proposed as useful markers in diagnosis, prediction of treatment response, monitoring treatment outcome or in understanding of etiology. This paper reviews five endocrine systems — the hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, growth hormone regulation, prolactin regulation and pineal function, in which such abnormalities have been reported. The dexamethasone suppression test (DST) results are affected by a variety of other diseases and confounding conditions. Furthermore, variability in dexamethasone availability has recently been shown to be an important factor, influencing post-DST cortisol levels. Refined tests, taking into account all these factors, or alternative tests of hypothalamic-pituitary-adrenal function may lead to improved clinical utility. Pineal function is now the focus of considerable investigation. Low nocturnal output of melatonin is found in unipolar and bipolar affective disorder and is normalized by treatment with antidepressant drugs which block re-uptake of noradrenaline. These findings support the hypothesis of noradrenergic abnormality in depression. In seasonal affective disorder there is evidence for a phase delay in the melatonin rhythm which may be a key factor in the seasonal disorder. Effective light therapy causes a phase advance in the abnormal melatonin rhythm. Whether the normalization of the melatonin rhythm is instrumental in producing the antidepressant effect is yet to be determined. There are wide spread neuroendocrine abnormalities in depressive illness. These abnormalities encompass many different pituitary hormones, as well as the pineal. Major theories of affective disorder attribute the mood and visceral changes to disruption in central neurotransmitter regulation or to altered central regulation of body rhythms, or to both. It is thought that disruption of these central systems give rise not only to the mood and visceral changes, but to the accompanying changes in endocrine regulation. Current diagnostic practice is to use clinical history and observation to identify typical forms of depression. Such an approach to diagnosis is less useful in delineating atypical, borderline or sub-clinical affective disorder. For these reasons, the endocrine changes have been proposed as biological markers to be used as clinical aids in diagnosis, prediction of treatment response, monitoring treatment outcome and in understanding etiology. This paper reviews and evaluates published data on five such endocrine measures.Keywords
This publication has 49 references indexed in Scilit:
- The DST and TRH Test in Bulimia NervosaThe British Journal of Psychiatry, 1989
- Judgement of the hypothalamic-pituitary-adrenocortical function in psychiatric patients by betamethasone-induced cortisol suppressibilityJournal of Neural Transmission, 1988
- Past and present strategies of research on the HPA‐axis in psychiatry.Acta Psychiatrica Scandinavica, 1988
- Lack of correlation between DST results and urinary MHPG in depressed inpatientsJournal of Neural Transmission, 1988
- Cortisol nonsuppression in depression: relationship to clinical variablesJournal of Affective Disorders, 1988
- The Role of Corticotropin-Releasing Factor in the Pathogenesis of Major DepressionPharmacopsychiatry, 1988
- A Comparison of the Growth Hormone Responses to Clonidine and Apomorphine in the Same Patients with Endogenous DepressionThe British Journal of Psychiatry, 1984
- Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosaThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Neuroendocrine responses to carbidopa in primary affective disordersPsychoneuroendocrinology, 1979
- Pituitary-adrenal function in depressed patients: Resistance to dexamethasone suppressionJournal of Psychiatric Research, 1975